From January 1, 2023 to March 31, 2023, the company has repurchased 263,131 shares, representing 0.55% for $8.01 million. With this, the company has completed the repurchase of 9,002,547 shares, representing 19.1% for $178.77 million under the buyback announced on November 8, 2016.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.33 USD | +0.43% | -2.15% | -31.56% |
05-22 | Sector Update: Health Care Stocks Slightly Higher Late Afternoon | MT |
05-22 | Sector Update: Health Care Stocks Advance Wednesday Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.56% | 2.07B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- AMPH Stock
- News Amphastar Pharmaceuticals, Inc.
- Tranche Update on Amphastar Pharmaceuticals, Inc.'s Equity Buyback Plan announced on November 8, 2016.